2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
Interest Income | 196,354 | -16.857% | 236,165 | 250,458 | 269,629 | 304,952 |
Interest Expense | (40,512) | -17.349% | (49,016) | (52,123) | (51,751) | (48,978) |
Net Interest Income | 155,842 | -16.728% | 187,149 | 198,335 | 217,878 | 255,974 |
Other Operating Income | 19,886 | -- | (12,677) | 9,930 | 34,066 | 7,681 |
Total Operating Income | 175,728 | 0.720% | 174,472 | 208,265 | 251,944 | 263,655 |
Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
Net Operating Income | 175,728 | 0.720% | 174,472 | 208,265 | 251,944 | 263,655 |
Operating Expenses | (45,908) | -13.186% | (52,881) | (53,416) | (57,658) | (52,750) |
Impairment Losses on Loans & Advances | (32,173) | -- | 7,836 | (17,835) | (18,877) | (43,992) |
Other Impairment Losses | (6,043) | -- | 1,664 | (4,419) | (2,246) | (4,841) |
Operating Profit / (Loss) | 91,604 | -30.122% | 131,091 | 132,595 | 173,163 | 162,072 |
Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
Profit / (Loss) before Taxation | 91,604 | -30.122% | 131,091 | 132,595 | 173,163 | 162,072 |
Taxation | (26,207) | -23.938% | (34,455) | (35,899) | (45,465) | (44,249) |
Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
Non-controlling Interests | (2,957) | -25.815% | (3,986) | (3,356) | (11,209) | (7,579) |
Others | -- | -- | -- | -- | -- | -- |
Profit / (Loss) Attributable to Shareholders | 62,440 | -32.607% | 92,650 | 93,340 | 116,489 | 110,244 |
2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
Depreciation & Amortisation | 5,161 | -17.766% | 6,276 | 8,131 | 8,249 | 7,884 |
Directors' Emoluments | -- | -- | -- | -- | -- | -- |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
EPS (cts) | 5.000 | -37.500% | 8.000 | 8.000 | 10.000 | 9.000 |
DPS (cts) | 1.270 | -- | 2.000 | 4.000 | 5.000 | 0.000 |
Dividend Payout Ratio (%) | 25.400% | -- | 25.000% | 50.000% | 50.000% | -- |
Cash flow per share ($) | 0.136 | -- | 0.241 | (0.005) | 0.060 | 0.126 |
NBV per share ($) | 1.681 | -- | 1.648 | 1.609 | 1.580 | 1.481 |
Remarks: | Real time quote last updated: 22/04/2025 17:59 |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
Profit / (Loss) Attributable to Shareholders (¥) | RMB 62,440,000 |
%Change | -32.607% |
EPS / (LPS) | RMB 0.050 |
NBV Per Share (¥) | RMB 1.681 |